Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Omicron

Covid incubation period: How long are you infectious for?

UK hit by fifth wave of infections earlier this summer driven by new Omicron variants

The Independent UK

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

News briefs

CDC advisers endorse booster shots that target omicron for Americans 12 and up

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Will work from home changes bring more workers back to the CBD?

Ballarat CBD businesses will be watching GovHub keenly in the weeks to come to see what impact the change of COVID work from home rules will have on the underutilised building. On Thursday Victorians were encouraged to return to the office, with the government lifting its work from home recommendation.…

The Canberra Times

CDC advisers endorse booster shots that target omicron for Americans 12 and up

The United States should replace most of its COVID-19 booster shots with updated versions that target the dominant omicron strains, an influential group of vaccine experts that advises the Centers for Disease Control and Prevention said Thursday.

Los Angeles Times

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

Benzinga

CDC recommends new booster shots to fight omicron

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Germany to start Omicron-adapted COVID vaccinations next week - minister

Germany can next week start using COVID-19 vaccines which have been adapted for the Omicron variant and got approval for use in the European Union on Thursday, Health Minister Karl Lauterbach said.

Reuters

CDC advisers weigh who needs updated COVID booster and when

Government advisers are debating who should should get new updated COVID-19 boosters and when

The Independent UK

EU regulator approves Omicron vaccines

The European Union’s drug regulator has recommended the use of two Omicron-tailored vaccines developed by the Pfizer-BioNTech partnership and Moderna Inc ahead of a fresh booster programme this fall across the continent.

Bangkok Post

EU regulator clears tweaked versions of COVID vaccines

The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant

The Independent UK

Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

The Conversation

What to know about new COVID boosters

Experts answer some top questions about Omicron-specific COVID boosters.

Axios

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

People vaccinated against Covid share common symptom after testing positive

Around one in five vaccinated Britons with Omicron or Delta strain experienced diarrhoea as a symptom

The Independent UK

Covid incubation period: How long are you infectious for?

UK hit by fifth wave of infections earlier this summer driven by new Omicron variants

AAP

Vic lifts work from home recommendation

Mandatory face masks on Victorian public transport are here to stay, but the state's work from home recommendation has been lifted.

Chicago Sun-Times

New COVID-19 booster shots could be available in Chicago after Labor Day

The FDA today authorized the new booster, which could arrive as early as next week in Chicago, where nearly 2 million residents are expected to be eligible.

Get all your
news in one place.

100’s of premium titles.
One news app.

Inverse

What are the side effects of the new Covid-19 bivalent booster?

Last week, the FDA authorized both Pfizer and Moderna's Omicron-specific jabs. Experts say to get them as soon as they are available to you.

The Independent UK

WHO: New COVID cases, deaths keep falling nearly everywhere

The number of new coronavirus cases and deaths reported globally continued to fall nearly everywhere in the world in what the World Health Organization described as a “welcome decline” at a media briefing on Wednesday

Daily Record

Covid alert level across UK downgraded as number of severe cases falls

The number of severe covid cases needing hospital care has decreased, leading to a lowering of the alert level.

Daily Mirror

UK Covid alert level downgraded from level 3 to 2 as cases fall and Omicron 'subsides'

A level two alert means that "Covid-19 is in general circulation but direct Covid-19 healthcare pressures and transmission are declining or stable"

The Independent UK

Covid-19 alert level downgraded as number of cases fall

The alert level has moved from three to two.

Tribune News Service

FDA clears way for boosters targeted at latest COVID variants

COVID-19 boosters from Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE that are tailored to the latest COVID-19 omicron variants got U.S. regulatory clearance, a move toward additional protection as concern grows about potential new waves in the fall and winter.

WEKU

FDA authorizes first revamp of COVID vaccines to target omicron

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

1 … 27 28 29 30

People

Tedros Adhanom Ghebreyesus

524 stories

Ginni Thomas

315 stories

Rafael Mariano Grossi

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

862 stories

Moderna

806 stories

UK Health Security Agency

501 stories

Food and Drug Administration

322 stories

Pfizer Inc

312 stories

Centers for Disease Control and Prevention

European Medicines Agency

76 stories

National Institutes of Health

76 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.